VEA
ZYME icon

Virtus ETF Advisers’s Zymeworks ZYME Stock Holding History

Virtus ETF Advisers’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,633
Closed -$82.5K – 812
2024
Q4 		$82.5K Sell
5,633
-4,481
-44% -$62.7K 0.03% 340
2024
Q3 		$127K Buy
10,114
+177
+2% +$1.93K 0.06% 344
2024
Q2 		$84.6K Buy
9,937
+332
+3% +$2.96K 0.04% 383
2024
Q1 		$101K Sell
9,605
-659
-6% -$7.32K 0.05% 361
2023
Q4 		$107K Sell
10,264
-1,607
-14% -$12.8K 0.07% 336
2023
Q3 		$75.3K Sell
11,871
-1,183
-9% -$8.74K 0.05% 371
2023
Q2 		$113K Sell
13,054
-2,705
-17% -$24.2K 0.07% 339
2023
Q1 		$142K Sell
15,759
-6,059
-28% -$52.8K 0.08% 319
2022
Q4 		$171K Buy
21,818
+3,838
+21% +$27K 0.09% 325
2022
Q3 		$111K Buy
17,980
+132
+0.7% +$796 0.04% 410
2022
Q2 		$95K Buy
17,848
+8,099
+83% +$49K 0.04% 432
2022
Q1 		$64K Sell
9,749
-575
-6% -$5.13K 0.03% 357
2021
Q4 		$169K Buy
10,324
+4,727
+84% +$98.6K 0.06% 293
2021
Q3 		$163K Sell
5,597
-297
-5% -$9.87K 0.07% 321
2021
Q2 		$204K Buy
5,894
+56
+1% +$1.78K 0.08% 332
2021
Q1 		$184K Buy
5,838
+112
+2% +$4.55K 0.08% 335
2020
Q4 		$271K Sell
5,726
-3,295
-37% -$153K 0.11% 272
2020
Q3 		$420K Sell
9,021
-1,227
-12% -$42.1K 0.22% 161
2020
Q2 		$370K Buy
10,248
+1,691
+20% +$62.3K 0.18% 237
2020
Q1 		$304K Sell
8,557
-1,252
-13% -$51.2K 0.13% 222
2019
Q4 		$446K Buy
+9,809
New +$356K 0.07% 223

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtus ETF Advisers's ZYME Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 5,633 shares — an estimated $82.5K sold.

Virtus ETF Advisers first reported a position in ZYME in Q4 2019 and held it in 21 quarters. The position peaked at $446K in Q4 2019. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 5,633 Zymeworks shares in Q1 2025, an estimated $82.5K.
  • Virtus ETF Advisers first reported a position in Zymeworks in Q4 2019 and held it in 21 quarters.
  • Virtus ETF Advisers's Zymeworks position peaked at $446K in Q4 2019.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.